Introduction
============

Twenty-seven patients in Wuhan City, Hubei Province of China were reported to have pneumonia of an unknown cause on December 31^st^, 2019 and were subsequently reported to have a novel coronavirus infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). After the announcement of 41 confirmed coronavirus disease 2019 (COVID-19) cases in Wuhan City, China on January 11^th^, infected patients were identified in Thailand on January 13^th^ and in Japan on January 16^th^. More cases were confirmed in some areas of China outside Wuhan, including Beijing and Shenzhen City, Guangdong Province on January 20^th^, and the number of confirmed cases has continued to rise. Moreover, there have been reports of secondary transmission from China and countries including Singapore, Japan, Thailand, Malaysia, and Vietnam into Korea \[[@b1-ophrp-11-8]\].

In Korea, 28 confirmed cases of COVID-19 had been reported as of February 14^th^, since the first case was confirmed on January 20^th^, 2020. Of these, 16 were cases imported into the country (57.1%) and 10 were believed to be secondary cases of infections originating in Korea; in the other 2 cases, the route of transmission remained undetermined.

The initial symptoms of COVID-19 are known to be respiratory symptoms such as coughing, in association with fevers, but the disease epidemiology remains largely unknown. To treat new infections and prevent further transmission, it is necessary to analyze and share epidemiological data on the cases reported to date \[[@b2-ophrp-11-8]\].

Materials and Methods
=====================

This is a case series of the 28 patients with confirmed COVID-19 in Korea as of February 14^th^, 2020. To obtain demographic, epidemiological, and early clinical information, COVID-19 reporting and surveillance data from Korea Centers for Disease Control and Prevention (KCDC), and the 28 case reports of the epidemiological investigation conducted by KCDC rapid response team was utilized.

Patient age was provided on the date of diagnosis, and key indicators such as estimated duration of exposure, date of onset of symptoms, and route of transmission were identified by an epidemiological investigator who participated in the field investigation and the epidemiological investigation team at KCDC headquarters. The incubation period was estimated based on the estimated exposure date and the date of symptom onset. However, it must be noted that the data presented in this study may change depending on the results of further epidemiological investigation.

Results
=======

1. Response to COVID-19 in Korea
--------------------------------

On December 31^st^, 2019, in Wuhan City, Hubei Province of China, 27 individuals developed pneumonia and all individuals had visited the seafood market in the area. The local centers for disease control and prevention, upon concluding that the novel infection had originated from overseas, established a "countermeasures taskforce against pneumonia of unknown cause" and set the crisis level to Blue. Accordingly, the situation overseas was constantly monitored, and surveillance in China was initiated, and responses initiated to suspected cases of infection. For suspected cases, a basic epidemiological assessment was conducted at the local health center and at the discretion of the central investigator, the patient was either admitted to a state-designated, negative-pressure isolation ward for further testing, or control measures of self-isolation and active surveillance were undertaken \[[@b3-ophrp-11-8]\].

On January 20^th^, the first case of infection from abroad was confirmed in Korea. Subsequently, the crisis level was scaled up from Blue to Yellow, and KCDC headquarters for the COVID-19 rapid response team was established. On January 27^th^, the crisis level was scaled up from Yellow to Orange, and the Ministry of Health and Welfare Central Accident Management Headquarters for the COVID-19 was established. Currently, all ministries of the government are cooperating in response to this novel emerging infectious disease.

In particular, to block the transmission of infection among patients under quarantine, Wuhan City was designated as an endemic center for infection on January 8^th^. Based on the health questionnaire filled out by travelers from Wuhan at the point of entry, people with body temperature higher than 37.5°C or respiratory symptoms including coughing were classified as symptomatic and isolated for testing. On January 23^rd^, Wuhan airport, which has an average of 300 travelers per day, was shut down by the Chinese government, and travel restrictions were implemented later in Hubei Province, including Wuhan City.

However, between January 20^th^ and January 28^th^, 4 patients who presented with symptoms outside of the Hubei province who had visited Wuhan, tested positive for SARS-CoV-2, and the number of cases outside Wuhan continued to increase. On January 28^th^, other areas in China where the infection was reported, were also quarantined. On February 4^th^, a special quarantine procedure was implemented on flights from China. The procedure not only involved the assessment of symptoms upon arrival, but also included the identification of individuals confirmed to have COVID-19 and those who had been in close contact with these infected individuals.

As of February 14^th^, a total of 7,242 patients were suspected of having COVID-19 and had been tested. Of those, 28 were confirmed to have COVID-19 of which 7 were discharged and 21 were treated.

2. Epidemiological characteristics
----------------------------------

Of the 28 patients with COVID-19, 15 were men (53.6%) and 13 were women (46.1%), with a mean age of 42.6 years (range: 20--73 years). Regarding age groups, 8 patients were in their 50's (28.6%), 6 patients each were in their 20's, 30's, and 40's (21.4%), and 1 patient each was in their 60's and 70's (3.6%). Of the 28 patients, 22 were Korean and 6 were Chinese, of whom 2 were visitors.

Of the 16 index cases imported from abroad (57.1%), 6 contributed to the occurrence of secondary infections in 10 patients in Korea. Of those with secondary infection, 7 were first-generation patients (25.0%) and 3 were second-generation patients (10.7%). In the remaining 2 patients (7.2%), the route of transmission remains under investigation.

The initial symptoms were fever or feeling hot (9 patients, 32.1%), sore throat (9 patients, 32.1%), cough or sputum production (5 patients, 17.9%), chills (5 patients, 17.9%), and muscle ache (4 patients, 14.3%). However, 3 patients were asymptomatic. In 18 patients, pneumonia was confirmed using imaging once hospitalized (64.3%). As of February 14^th^, 7 out of 28 patients had been discharged, and the average length of hospital stay was 12.7 days (range: 8--19 days).

One patient had visited a marketplace in China, while 2 had visited a medical facility in Wuhan City. Of the 28 patients, 10 (35.7%) had at least 1 underlying disease including hypertension, diabetes, asthma, chronic rhinitis, dyslipidemia, and hypothyroidism, and 1 patient had undergone surgery for lung cancer ([Table 1](#t1-ophrp-11-8){ref-type="table"}).

"Test count" refers to the number of cases that were reported to KCDC by local health centers and were then tested. Prior to February 7^th^, tests were conducted by KCDC and the Research Institute of Public Health and Environment in the corresponding cities/provinces, the number of reports and test counts matched. After February 7^th^, additional tests were conducted for each individual suspected of having COVID-19 increasing the number of reports, aside from those initially conducted by the local health center.

The earliest date of symptom onset among the 25 patients with a clear date of onset, was January 10^th^ (for 3 patients, the date of onset was unclear). Since then, the number of confirmed index cases imported from abroad continued to increase, and symptoms were first confirmed in patients with secondary infection on January 26^th^. The incubation period was estimated to be 4.1 days based on the date of symptom onset and first exposure (among 9 patients, excluding 1 patient with an unclear date of onset) shown in [Figure 1](#f1-ophrp-11-8){ref-type="fig"} and [Table 2](#t2-ophrp-11-8){ref-type="table"}.

In the 16 index cases imported from abroad, the suspected sites where the infection was first contracted were Wuhan, China (11 cases, 68.3%), Singapore (2 cases, 12.5%), Zhuhai, China (1 case, 6.3%), Thailand (1 case, 6.3%), and Japan (1 case, 6.3%). The 10 patients with secondary infection for which the routes of transmission were known were either family members (7 cases, 70.0%) including relatives (2 cases), or acquaintances (3 cases, 30%) of the primary patients. The suspected sites of transmission were the home (7 cases, 70.0%), a restaurant (1 case, 10.0%), a church (1 case, 10.0%), and other locations (1 case, 10.0%).

With regard to the distribution of the 24 cases by region, excluding the 2 Wuhan residents and 2 patients who were evacuated via a charter flight, high incidence rates were reported in Gyeonggi-do (11 patients, 39.3%) and Seoul (9 patients, 32.1%), followed by Gwangju (2 patients, 7.1%), and Jeollabuk-do and Jeollanam-do (1 patient each, 3.6%) shown in [Table 2](#t2-ophrp-11-8){ref-type="table"}.

3. Confirming the route of transmission
---------------------------------------

Regarding the course of disease development in the 28 patients with confirmed COVID-19 as of February 14^th^, 6 patients developed secondary infection, which they contracted from previously infected individuals, with each group including 2--6 patients ([Figure 2](#f2-ophrp-11-8){ref-type="fig"}).

The first group included the following index patients: Patient \#3 was a 54-year-old man who was asymptomatic upon arrival in Korea on January 20^th^, but had developed a fever, chills, muscle ache, and nasal congestion by 13:00 on January 22^nd^. Patient \#28, who was on the same flight bound from Wuhan to Korea as Patient \#3, tested positive on February 10^th^ during self-quarantine. The route of transmission is still under investigation. In addition, since Patient \#28 underwent surgery following entry into the country, and was treated with antibiotics and analgesics, the exact date of onset of symptoms could not be calculated. Patient \#6, an acquaintance of Patient \#3, dined at a restaurant with Patient \#3 on the evening of January 22^nd^ for an hour and a half, developed symptoms including the chills on January 26^th^, and tested positive for COVID-19 on January 30^th^. Patients \#10 and \#11, the wife and son of Patient \#6 who lived and dined at the restaurant with him, developed symptoms on January 29^th^ and 30^th^, respectively, and tested positive for COVID-19. Patient \#21, an acquaintance of Patient \#6 who attended on January 26^th^, developed symptoms on January 30^th^ and subsequently tested positive for COVID-19.

The index case imported from abroad in the second group involved Patient \#5, a 32-year-old man from Wuhan who visited Korea on January 24^th^ and started to develop aches similar to that observed in the common cold on January 26^th^. Patient \#9, who developed a secondary infection, was an acquaintance of Patient \#5 who stayed and dined at the same place as Patient \#9 until January 29^th^. Patient \#9 developed a headache on January 30^th^, was managed as a contact case, and tested positive on January 31^st^.

The third index case imported from abroad involved Patient \#12, a 48-year-old man with a history of contact for business reasons, with a Japanese patient who had tested positive for COVID-19 in Japan. This was the first case imported from a country outside China. Following entry to Korea on January 19^th^, the patient started experiencing muscle aches on January 20^th^. However, COVID-19 was not suspected because he arrived in Korea from Japan, and thus reporting/testing was delayed. Patient \#14 was his wife who stayed with him for more than 10 days before COVID-19 was confirmed. She developed symptoms on January 29^th^ and subsequently tested positive.

The fourth index case involved Patient \#15, a 43-year-old man who was being monitored after having close contact with Patient \#4 on the plane. He developed a fever and a sore throat on February 1^st^ and subsequently tested positive. Patient \#20, a relative living in the same building but on a different floor, experienced a sore throat on February 4^th^ and subsequently tested positive. It is likely that he was infected whilst eating with Patient \#15.

The index case imported from abroad in the fifth group involved Patient \#16, a 42-year-old woman who developed chills on January 25^th^ after visiting Thailand and tested positive on February 4^th^. Since Patient \#16 developed symptoms after visiting Bangkok and Pattaya, Thailand, between January 15^th^ and January 19^th^, it is probable that she was either infected at a tourist destination in Thailand or Bangkok airport. The daughter of Patient \#16 tested positive on February 5^th^ and was designated as Patient \#18. Among the other family members who dined with Patient \#18 at her mother's house on January 25^th^, the older brother (Patient \#22) tested positive for COVID-19 on February 5^th^. Patients \#18 and \#22 were initially asymptomatic. Hence, the date of symptom onset could not be estimated. Moreover, Patient \#18 had an overlapping history of visiting Thailand and a hospital visit with Patient \#16 in Korea thus, the route of transmission was unclear and remained under investigation.

The sixth transmission case originating in Korea involved Patient \#25, a 73-year-old woman who tested positive at a screening clinic. Later, her son (Patient \#26) and daughter-in-law (Patient \#27) tested positive during the process of epidemiological investigation. After patients \#26 and \#27 entered Korea on January 31^st^ from Zhuhai, Guangdong Province of China, via Macau, the 3 patients remained in the same place of residence in Korea. Considering that Patient \#27 developed symptoms on February 4^th^, earlier than Patients \#25 and \#26, and Patient \#25 did not have any previous history of overseas travel, it is likely that Patients \#25 and \#26 were infected by Patient \#27.

Of the 10 patients with secondary infection and known routes of transmission, 7 were family members including 2 relatives and 3 were acquaintances. All these patients either dined or resided together. Transmission from patients \#3 to \#6, and from patients \#16 to \#22 was assumed to have taken place while they dined together at the same place. Patients \#6 and \#21 did not dine together, but were together for 2 hours at a chapel. Regarding transmission, patients with secondary infection had a history of close contact with the primary patient including physical contact, co-dining, and co-habitation for a considerable amount of time.

In summary, of the 28 confirmed cases, 16 were index cases imported from abroad, 10 were secondary infection cases, and 2 remained under investigation to determine the route of transmission. As of February 14^th^, the 28 patients had come into close contact with 1,781 people, of whom 1,356 were released from surveillance, and 457 were under self-quarantine, and active surveillance. The suspected sites of transmission for the 10 patients with secondary infection were the home (7 patients, 60.0%), a restaurant, a church, and other locations (1 patient each, 8.3%). The relationship between the primary patient and patients with secondary infection were as follows: family (7 patients, 70.0%, including 2 relatives) and acquaintances (3 patients, 30.0%). This finding suggests that secondary infection occurred among individuals who were in close contact with an infected person for a considerable amount of time whilst they lived and dined together.

Discussion
==========

Among the Korean patients, 15 were men (53.9%). It has been reported that 56%--73.2% of confirmed cases of COVID-19 in Wuhan, China are in men \[[@b4-ophrp-11-8],[@b5-ophrp-11-8]\]. The estimated incubation period was 4.6 days to develop COVID-19, which was shorter than the period of 5.2 days reported in China \[[@b5-ophrp-11-8]\]. The mean age of the Korean patients was 42.6 years, which was lower than the age reported in previous studies conducted in China (49 years, 55.5 years, and 59 years) \[[@b2-ophrp-11-8],[@b4-ophrp-11-8],[@b5-ophrp-11-8]\].

Chen et al \[[@b2-ophrp-11-8]\] and Huang et al \[[@b4-ophrp-11-8]\] also reported that 32--51% of the hospitalized patients with confirmed COVID-19 had hypertension, diabetes, and cardiovascular diseases, while 10 of the 28 Korean patients (35.7%) had at least 1 underlying disease, including hypertension and diabetes. In addition, the early symptoms, such as a fever, coughing, a sore throat, the chills, and muscle ache, were similar to the reported symptoms of COVID-19 \[[@b4-ophrp-11-8]\].

Currently, the COVID-19 cases originating in Korea have been reported to be index cases imported from abroad, and resultant first-generation and second-generation cases. So far, all the patients confirmed to have COVID-19 have identifiable epidemiological connections. In other words, cases of secondary infection were limited to closely related people (family and acquaintances) who spent time together co-dining and co-habiting. It is important to analyze and share such epidemiological and clinical data on COVID-19 to establish an effective response strategy.
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###### 

Demographic characteristics of 28 COVID-19 patients in South Korea (*N* = 28).

  Variables                                                                                                                        *n*    \%
  ------------------------------------------------- ------------------------------------------------------------------------------ ------ ------
  Gender                                                                                                                                  
                                                    Male                                                                           15     53.6
  Female                                            13                                                                             46.4   
                                                                                                                                          
  Age (y)                                                                                                                                 
                                                    20--29                                                                         6      21.4
                                                    30--39                                                                         6      21.4
                                                    40--49                                                                         6      21.4
                                                    50--59                                                                         8      28.6
                                                    60--69                                                                         1      3.6
                                                    70--79                                                                         1      3.6
                                                                                                                                          
  Nationality                                                                                                                             
                                                    Korean                                                                         22     78.6
  Chinese                                           6                                                                              21.4   
                                                                                                                                          
  Signs and Symptoms at onset (may be duplicated)                                                                                         
                                                    Fever                                                                          9      32.1
                                                    Sore Throat                                                                    9      32.1
                                                    Cough or Sputum                                                                5      17.9
                                                    Chills                                                                         5      17.9
                                                    Muscle ache                                                                    4      14.3
                                                    Generalized weakness                                                           3      10.7
                                                    Headache                                                                       3      10.7
                                                    Asymptomatic infection or Unknown[\*](#tfn1-ophrp-11-8){ref-type="table-fn"}   3      10.7
                                                                                                                                          
  Pneumonia after admission                                                                                                               
                                                    Pneumonia                                                                      18     64.3

Unknown: due to treatment with antibiotics and analgesics after surgery.

COVID-19 = coronavirus disease 2019.

###### 

Epidemiological characteristics of 28 patients with COVID-19 in South Korea (*N* = 28).

  Source of infection                                                                *n*          \%
  -------------------------------------------------------------- ------------------- ------------ -------
  Case imported                                                                                   
                                                                 Wuhan, China        11           68.8
                                                                 Zhuhai, China       1            6.3
                                                                 Japan               1            6.3
                                                                 Singapore           2            12.5
                                                                 Thailand            1            6.3
                                                                                                  
  Local transmission site                                                                         
                                                                 Residence           7            70.0
                                                                 Outside residence   3            30.0
                                                                 Hospital            \-           \-
                                                                 Airplane            \-           \-
                                                                                                  
  Relationship in local transmission                                                              
                                                                 Family              5            50.0
                                                                 Relatives           2            20.0
                                                                 Acquaintance        3            30.0
                                                                 Co-worker           \-           \-
                                                                                                  
                                                                                     Mean ± SD    Range
                                                                                                  
  Incubation period[\*](#tfn3-ophrp-11-8){ref-type="table-fn"}                       4.1 ± 1.85   2--9

Local transmission *n* = 9 (except 1 with unknown onset date of symptoms).

COVID-19 = coronavirus disease 2019.
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